Literature DB >> 31622694

Personal perspectives and concerns over the so-called nanomedicine.

Victor C Yang1.   

Abstract

Year:  2019        PMID： 31622694     DOI： 10.1016/j.jconrel.2019.10.021

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


× No keyword cloud information.
  4 in total

1.  An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid-Modified EPI-Loaded Liposomes Inhibit Breast Cancer Metastasis.

Authors:  Xianmin Meng; Mingqi Wang; Kaituo Zhang; Dezhi Sui; Meng Chen; Zihan Xu; Tiantian Guo; Xinrong Liu; Yihui Deng; Yanzhi Song
Journal:  AAPS PharmSciTech       Date:  2022-10-18       Impact factor: 4.026

Review 2.  Towards principled design of cancer nanomedicine to accelerate clinical translation.

Authors:  Mohammad Souri; M Soltani; Farshad Moradi Kashkooli; Mohammad Kiani Shahvandi; Mohsen Chiani; Fatemeh Sadat Shariati; Mohammad Reza Mehrabi; Lance L Munn
Journal:  Mater Today Bio       Date:  2022-02-01

3.  Polymers prepared through an "ATRP polymerization-esterification" strategy for dual temperature- and reduction-induced paclitaxel delivery.

Authors:  JingWen Xu; ZhuoMiao Cui; Xin Ge; YanLing Luo; Feng Xu
Journal:  RSC Adv       Date:  2020-08-04       Impact factor: 4.036

Review 4.  Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies.

Authors:  Yun Liu; Jianfeng Guo; Leaf Huang
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.